Hers vs Hims: GLP-1 Telehealth Provider Comparison
Compare Hers (FDA-approved brand-name) and Hims (FDA-approved brand-name). Insurance acceptance, shipping, FDA compliance.
Informational comparison only — not medical advice. Your prescriber decides what's right for you.
Quick answer
Compare Hers (FDA-approved brand-name) and Hims (FDA-approved brand-name). Insurance acceptance, shipping, FDA compliance.
- Hers FDA-approved for: See FDA label
- Hims FDA-approved for: See FDA label
- Hers starting price: $298/month
- Hims starting price: $298/month
Quick visual breakdown
Hers wins 0 · Hims wins 0
Hers
0 of 4 wins
Hims
0 of 4 wins
Side-by-side comparison
We don't pick a winner here
Hers and Hims score the same against our criteria, so naming one would tell you more about our tie-breaking than about the two options. They differ on things a score cannot rank for you — the table above is where the decision actually gets made. Read the rows that match your situation: what you pay, what is in stock, and whether the route is FDA-approved or compounded.
Neutral comparator. We run no clinic and never sell medication — we earn the same commission whoever you pick, so this ranking is editorial, not pay-to-rank. Methodology · How we make money
Where to start
Partner offers first — we earn a commission from those — then ranked by our editorial score. We earn a commission if you start a consultation through these links — it never changes your price.
Compounded options are not FDA-approved as finished products.
- Sesame Care
Our score 8.2/10
$208/mo
Get from $208/mo $199/mo
Get from $199/mo- Get started
$165/mo
Get from $165/mo
People also compare
Common questions about Hers
Are the medications the same quality?
Both offer FDA-approved brand-name medications subject to manufacturer quality controls.
Further reading (authoritative sources)
- Prescription medications to treat overweight & obesity — NIH — NIDDKGovernment overview of approved weight-management drugs.
- GLP-1 agonists — overview & how they work — NIH — MedlinePlus
- FDA's concerns with unapproved GLP-1 drugs used for weight loss — U.S. FDA
- Medicaid coverage of and spending on GLP-1s — KFFState-by-state coverage data (2026).